These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 24094206)
1. Curcumin containing monoolein aqueous dispersions: a preformulative study. Esposito E; Ravani L; Mariani P; Contado C; Drechsler M; Puglia C; Cortesi R Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4923-34. PubMed ID: 24094206 [TBL] [Abstract][Full Text] [Related]
2. Effect of nanostructured lipid vehicles on percutaneous absorption of curcumin. Esposito E; Ravani L; Mariani P; Huang N; Boldrini P; Drechsler M; Valacchi G; Cortesi R; Puglia C Eur J Pharm Biopharm; 2014 Feb; 86(2):121-32. PubMed ID: 24361485 [TBL] [Abstract][Full Text] [Related]
3. Monoolein aqueous dispersions as a delivery system for quercetin. Cortesi R; Cappellozza E; Drechsler M; Contado C; Baldisserotto A; Mariani P; Carducci F; Pecorelli A; Esposito E; Valacchi G Biomed Microdevices; 2017 Jun; 19(2):41. PubMed ID: 28484916 [TBL] [Abstract][Full Text] [Related]
4. Effect of new curcumin-containing nanostructured lipid dispersions on human keratinocytes proliferative responses. Esposito E; Sticozzi C; Ravani L; Drechsler M; Muresan XM; Cervellati F; Cortesi R; Valacchi G Exp Dermatol; 2015 Jun; 24(6):449-54. PubMed ID: 25808217 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of monooleine aqueous dispersions as tools for topical administration of curcumin: characterization, in vitro and ex-vivo studies. Puglia C; Cardile V; Panico AM; Crascì L; Offerta A; Caggia S; Drechsler M; Mariani P; Cortesi R; Esposito E J Pharm Sci; 2013 Jul; 102(7):2349-61. PubMed ID: 23686742 [TBL] [Abstract][Full Text] [Related]
6. Antioxidant-containing monoolein aqueous dispersions: a preliminary study. Sguizzato M; Drechsler M; Baldisserotto A; Cortesi R; Esposito E Drug Deliv Transl Res; 2022 Aug; 12(8):1873-1880. PubMed ID: 35084708 [TBL] [Abstract][Full Text] [Related]
7. Clotrimazole nanoparticle gel for mucosal administration. Esposito E; Ravani L; Contado C; Costenaro A; Drechsler M; Rossi D; Menegatti E; Grandini A; Cortesi R Mater Sci Eng C Mater Biol Appl; 2013 Jan; 33(1):411-8. PubMed ID: 25428089 [TBL] [Abstract][Full Text] [Related]
8. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Esposito E; Cortesi R; Drechsler M; Paccamiccio L; Mariani P; Contado C; Stellin E; Menegatti E; Bonina F; Puglia C Pharm Res; 2005 Dec; 22(12):2163-73. PubMed ID: 16267633 [TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid dispersions for topical administration of crocin, a potent antioxidant from saffron (Crocus sativus L.). Esposito E; Drechsler M; Mariani P; Panico AM; Cardile V; Crascì L; Carducci F; Graziano ACE; Cortesi R; Puglia C Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():669-677. PubMed ID: 27987758 [TBL] [Abstract][Full Text] [Related]
10. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study. Esposito E; Mariani P; Ravani L; Contado C; Volta M; Bido S; Drechsler M; Mazzoni S; Menegatti E; Morari M; Cortesi R Eur J Pharm Biopharm; 2012 Feb; 80(2):306-14. PubMed ID: 22061262 [TBL] [Abstract][Full Text] [Related]
11. Characterization of cubosomes as a targeted and sustained transdermal delivery system for capsaicin. Peng X; Zhou Y; Han K; Qin L; Dian L; Li G; Pan X; Wu C Drug Des Devel Ther; 2015; 9():4209-18. PubMed ID: 26345516 [TBL] [Abstract][Full Text] [Related]
12. Monoolein liquid crystalline phases for topical delivery of crocetin. Esposito E; Carducci F; Mariani P; Huang N; Simelière F; Cortesi R; Romeo G; Puglia C Colloids Surf B Biointerfaces; 2018 Nov; 171():67-74. PubMed ID: 30015140 [TBL] [Abstract][Full Text] [Related]
13. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A. Lopes LB; Ferreira DA; de Paula D; Garcia MT; Thomazini JA; Fantini MC; Bentley MV Pharm Res; 2006 Jun; 23(6):1332-42. PubMed ID: 16715364 [TBL] [Abstract][Full Text] [Related]
14. Transformation of vesicular into cubic nanoparticles by autoclaving of aqueous monoolein/poloxamer dispersions. Wörle G; Siekmann B; Koch MH; Bunjes H Eur J Pharm Sci; 2006 Jan; 27(1):44-53. PubMed ID: 16157479 [TBL] [Abstract][Full Text] [Related]
15. Influence of composition and preparation parameters on the properties of aqueous monoolein dispersions. Wörle G; Drechsler M; Koch MH; Siekmann B; Westesen K; Bunjes H Int J Pharm; 2007 Feb; 329(1-2):150-7. PubMed ID: 16987623 [TBL] [Abstract][Full Text] [Related]
16. Effect of drug loading on the transformation of vesicular into cubic nanoparticles during heat treatment of aqueous monoolein/poloxamer dispersions. Wörle G; Siekmann B; Bunjes H Eur J Pharm Biopharm; 2006 Jun; 63(2):128-33. PubMed ID: 16497495 [TBL] [Abstract][Full Text] [Related]
17. Cryo-TEM investigation of phase behaviour and aggregate structure in dilute dispersions of monoolein and oleic acid. Ferreira DA; Bentley MV; Karlsson G; Edwards K Int J Pharm; 2006 Mar; 310(1-2):203-12. PubMed ID: 16439076 [TBL] [Abstract][Full Text] [Related]
18. The clinical efficacy of cosmeceutical application of liquid crystalline nanostructured dispersions of alpha lipoic acid as anti-wrinkle. Sherif S; Bendas ER; Badawy S Eur J Pharm Biopharm; 2014 Feb; 86(2):251-9. PubMed ID: 24056055 [TBL] [Abstract][Full Text] [Related]
19. Effect of Vesicle-to-Micelle Transition on the Interactions of Phospholipid/Sodium Cholate Mixed Systems with Curcumin in Aqueous Solution. Zhang S; Wang X J Phys Chem B; 2016 Aug; 120(30):7392-400. PubMed ID: 27403579 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems. Lopes LB; Speretta FF; Bentley MV Eur J Pharm Sci; 2007 Nov; 32(3):209-15. PubMed ID: 17900879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]